DALLAS, July 16, 2010 (GLOBE NEWSWIRE) -- MicroStockProfit.com announces an investment report featuring Verenium Corp. (Nasdaq:VRNM). The report includes financial, comparative and investment analyses, and recent company news that you need to know to make an educated investment decision.
Our trade alerts and ideas are provided free to investors. Simply use your email address to subscribe with http://www.microstockprofit.com to get the inside track on our next red-hot alert.
The full report is available at: http://www.microstockprofit.com/lp/VRNM
VRNM's recent volatility has been greater than normal. This is evidenced by the increased distance between the upper and lower Bollinger Bands. These bands measure volatility using standard deviation and a large width is due to high volatility. Additionally, VRNM is trading above its upper Bollinger Band. Relative to recent price action, the stock is currently overextended and due for either a pause or retracement.
Verenium Corp. (VRNM) possesses a portfolio of specialty enzyme products. The Company operates in two segments: biofuels and specialty enzymes. Its biofuels business segment is focused on developing technical and operational capabilities designed to enable the production and commercialization of biofuels, in particular ethanol from cellulosic biomass. Its specialty enzymes business segment develops customized enzymes for use within the alternative fuels, specialty industrial processes, and animal nutrition and health markets.
Message Board Search for VRNM: http://www.boardcentral.com/boards/VRNM
In the report, the analyst notes:
"Total revenues for the quarter ended March 31, 2010, were $13.0 million compared to $14.4 million for the same period in the prior year, with product revenues representing 89% of total revenues for the three months ended March 31, 2010, compared to 73% for the same period in the prior year.
"BP and VRNM recently announced an agreement for BP Biofuels North America to acquire VRNM's cellulosic biofuels business, including the Company's facilities in Jennings, La., and San Diego, Calif., for $98.3 million. VRNM will retain its commercial enzyme business, including its biofuels enzymes products and have the right to develop its own lignocellulosic enzyme program. VRNM will also retain select R&D capabilities, as well as rights to access select biofuels technology developed by BP using the technology it is acquiring from VRNM through this agreement."
To read the entire report visit: http://www.microstockprofit.com/lp/VRNM
See what investors are saying about VRNM at penny stock forum
MicroStockProfit.com Disclosure
MicroStockProfit.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. MicroStockProfit.com is a Web site wholly owned by BlueWave Advisors, LLC. Neither MicroStockProfit.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. Please read our report and visit our Web site, MicroStockProfit.com, for complete risks and disclosures.